Award-winners Lectures 1
Rafaelsen Young Investigators Award

[AW1-3] Initial data implicating the use of ketamine as a targeted treatment for depression in Parkinson’s disease

Yanghong Yang¹, Mika Naganawa¹, Mina Ansari¹, Sophie Elliott¹, Praveen Honhar¹, Mark Dias¹, Shannan Henry¹, Robert Comley², Nabeel Nabulsi², Yiyun Huang¹, Richard Carson¹, Sjoerd Finnema², Sina Nikayin¹, David Matuskey¹, Sule Tinaz¹, Gerard Sanacora¹, *Sophie E Holmes¹ (1. Yale University , 2. Abbvie)

Keywords:Depression, Ketamine, Neuroimaging